Financials · mywealthgrid

Standalone figures · ₹ crore

₹ Cr	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	953	805	911	811	1,000	946	966	805	974	1,023	989	924
COGS	350	314	349	293	377	351	346	288	351	349	336	316
Gross profit	603	491	562	518	623	595	620	517	623	674	653	608
	317	274	306	289	304	305	289	266	288	306	306	315
	287	218	255	229	319	290	331	251	335	368	347	293
OPM %	30.1%	27%	28%	28.3%	31.9%	30.7%	34.2%	31.2%	34.4%	36%	35.1%	31.7%
Depreciation	18	17	18	16	17	19	15	16	17	20	13	16
Interest	0	0	1	0	0	0	1	0	1	1	1	1
	28	-135	32	36	37	35	39	44	34	32	36	62
Profit before tax	297	65	269	248	339	306	355	279	351	378	369	338
Tax	81	20	76	67	90	78	95	74	96	101	94	85
Tax %	27.3%	30.1%	28.2%	26.9%	26.6%	25.4%	26.7%	26.5%	27.3%	26.7%	25.5%	25.1%
	216	45	193	182	249	229	260	205	255	277	275	253
PAT margin %	22.6%	5.7%	21.2%	22.4%	24.9%	24.2%	26.9%	25.4%	26.2%	27.1%	27.8%	27.4%
EPS (₹)	12.7	9.9	11.4	10.7	14.5	13.5	15.4	12.1	14.9	16.4	16.2	15
Results filing	—	—	—	—	—	—	—	Results filing for Jun 2025	Results filing for Sep 2025	Results filing for Dec 2025	Results filing for Mar 2026	Results filing for Jun 2026

vs same quarter last year	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue YoY %	+5.3%	+0.7%	+16.5%	+9.9%	+4.9%	+17.6%	+6.1%	-0.8%

Glaxosmithkline Pharmaceuticals Limited